Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study

NCT07662928 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
43
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

AIDS Malignancy Consortium

Collaborators